Yusuf Khwaja Hamied
Chairman en CIPLA LIMITED .
Fortuna: 2 697 M $ al 31/03/2024
Perfil
Yusuf Khwaja Hamied es presidente no ejecutivo de Cipla Ltd. y presidente de Cipla Medpro Pty Ltd. (filial de Cipla Ltd.). Se doctoró en la Universidad de Cambridge.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CIPLA LTD
18.64% | 30/06/2023 | 150 521 183 ( 18.64% ) | 2 697 M $ | 31/03/2024 |
Cargos activos de Yusuf Khwaja Hamied
| Empresas | Cargo | Inicio |
|---|---|---|
| CIPLA LIMITED | Chairman | 21/07/1972 |
Cipla Medpro Pty Ltd.
 Cipla Medpro Pty Ltd. BiotechnologyHealth Technology Cipla Medpro Pty Ltd. engages in pharmaceutical products production. Its offers asthma, allergy, colds and flu, complementary medicines, cough, diabetes management, Reydin, anthelmintic, antibiotics, antidiabetics and neuropsychiatry products. The company was founded in 1995 and is headquartered in Bellville, South Africa. | Chairman | - |
Formación de Yusuf Khwaja Hamied.
| University of Cambridge | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CIPLA LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
Cipla Medpro Pty Ltd.
Cipla Medpro Pty Ltd. BiotechnologyHealth Technology Cipla Medpro Pty Ltd. engages in pharmaceutical products production. Its offers asthma, allergy, colds and flu, complementary medicines, cough, diabetes management, Reydin, anthelmintic, antibiotics, antidiabetics and neuropsychiatry products. The company was founded in 1995 and is headquartered in Bellville, South Africa. | Health Technology |
- Bolsa de valores
- Insiders
- Yusuf Khwaja Hamied
